Protein release from gelatin matrices

Advanced Drug Delivery Reviews

Volumn 31, Issue 3, 1998, Pages 287-301

  Tabata, Yasuhiko ^a   Ikada, Yoshito ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Bone formation; Degradation; Gelatin; Growth factor; Neovascularization; Polyion complexation; Sustained release

Indexed keywords

BIODEGRADATION; BONE; COMPLEXATION; CROSSLINKING; ENZYMES; HORMONES; HYDROGELS; POLYSACCHARIDES;

GELATIN; NEOVASCULARIZATION; POLYIONS;

CONTROLLED DRUG DELIVERY;

BASIC FIBROBLAST GROWTH FACTOR; GELATIN; PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; BIODEGRADATION; BONE DEFECT; BONE DENSITY; BONE MINERAL; COMPLEX FORMATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; HYDROGEL; IMPLANT; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RABBIT; SUBCUTANEOUS DRUG ADMINISTRATION; SUSTAINED RELEASE PREPARATION;

EID: 0032482156     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00125-7     Document Type: Review

References (105)

1. M.C. Manning, K. Patel, T. Borchardt, Stability of protein pharmaceutical, Pharm. Res. 6 (1989) 903-918.
2. Y.J. Wang, A. Hanson, Parenteral formulations of proteins and peptides: stability and stabilizers, J. Parenter. Sci. Technol. Suppl. 42 (1988) S3-S26.
3. L.M. Sanders, G.I. McRae, K.M. Vitale, B.A. Kell, Controlled delivery of a LHRH analogue from biodegradable injectable microspheres, J. Control. Release 2 (1985) 187-195.
4. M. Asano, M. Yoshida, I. Kaetsu, K. Imai, T. Mashimo, H. Yuasa, H. Yamanaka, K. Suzuki, I. Yamazaki, Biodegradability of hot-pressed poly(lactic acid) formulation with controlled release LHRH agonist and its pharmacological influence on rat prostate, Makromol. Chem., Rapid Commun. 6 (1985) 509-513.
5. F.G. Hutchinson, B.J.A. Furr, Biodegradable polymers for the sustained release of peptides, Biochem. Soc. Trans. 13 (1985) 520-523.
6. A.K. Kwong, S. Chou, A.M. Sun, M.V. Sefton, M.F.A. Goosen, In vitro and in vivo release of insulin from poly(lactic acid) microbeads and pellets, J. Control. Release 4 (1986) 47-62.
7. H.V. Maulding, Prolonged delivery of peptides by microcapsules, J. Control. Release 6 (1987) 167-176.
8. S.-Y. Lin, L.-T. Ho, H.L. Chiou, Insulin controlled release microcapsules to prolong the hypoglycemic effect in diabetic rats, Artif. Cells Artif. Org. 16 (1988) 815-828.
9. M.S. Hora, R.K. Rana, J.H. Nunberg, T.R. Tice, R.M. Gilley, M.E. Hudson, Release of human serum albumin from poly(lactide-co-glycolide) microspheres, Pharm. Res. 7 (1990) 1190-1194.
10. P.J. Watts, M.C. Dais, C.D. Melia, Microencapsulation using emulsion/solvent evaporation: An overview of techniques and applications, CRC Crit. Rev. Ther. Drug Carrier Syst. 7 (1990) 235-259.
11. M.S. Hora, R.K. Rana, J.H. Nunberg, T.R. Tice, R.M. Gilley, M.E. Hudson, Controlled release of interleukin-2 from biodegradable microspheres, Bio/Technology 8 (1990) 755-758.
12. N. Marcotte, A. Polk, M.F.A. Gosen, Kinetics of protein diffusion from poly(D,L-lactide) reservoir systems, J. Pharm. Sci. 79 (1990) 407-410.
13. R.E. Johnson, L.A. Lanaski, V. Gupta, M.J. Griffin, H.T. Gaud, T.E. Neehdam, H. Zia, Stability of atriopeptin III in poly(D,L-lactide-co-glycolide) microspheres, J. Control. Release 17 (1991) 61-68.
14. S. Cohen, T. Yoshioka, M. Lucarelli, L.H. Hwang, R. Langer, Controlled delivery of systems for proteins based on poly(lactic/glycolic acid) microspheres, Pharm. Res. 8 (1991) 713-720.
15. M. Singh, A. Singh, G.P. Talwar, Controlled delivery of diphtheria toxoid using biodegradable poly(D,L-lactide) macrocapsules, Pharm. Res. 8 (1991) 958-961.
16. D. Bodmer, T. Kissel, E. Traechslin, Factors influencing the release of peptides and proteins from biodegradable parenteal depot systems, J. Control. Release 21 (1992) 129-138.
17. P.J. Camarata, R. Suryanarayanan, D.A. Turner, R.G. Parke, T.J. Ebner, Sustained release of nerve growth factor from biodegradable polymer microspheres, Neurosurgery 30 (1992) 313-319.
18. T.G. Park, S. Cohen, R. Langer, Controlled protein release from polyethyleneimine-coated poly(L-lactic acid)/pluronic blend matrices, Pharm. Res. 9 (1992) 37-39.
19. W.R. Gombotz, S.C. Pankey, L.S. Bouchard, J. Ranchalis, P. Puolakkainen, Controlled release of TGF-β1 from a biodegradable matrix for bone regeneration, J. Biomater. Sci., Polym. Ed. 5 (1993) 46-63.
20. Y. Tabata, Y. Takebayashi, T. Ueda, Y Ikada, A formulation method using D,L-lactic acid oligomer for protein release with reduced initial burst, J. Control. Release 23 (1993) 55-64.
21. M. Alonso, S. Cohen, T.G. Park, R.K. Gupta, G.R. Siber, R. Langer, Determinants of release of tetanus vaccine from polyester microspheres, Pharm. Res. 10 (1993) 945-953.
22. A. Sopersaxo, J.H. Kou, P. Teitelbaum, R. Maskiewicz, Preformed porous microspheres for controlled and pulsed release of macromolecules, J. Control. Release 23 (1993) 157-164.
23. X. Zhang, U.P. Wyss, D. Pichora, B. Amsden, M.F.A. Goosen, Controlled release of albumin from biodegradable poly(DL-lactide) cylinders, J. Control. Release 25 (1993) 61-69.
24. H. Okada, Y. Doken, Y. Ogawa, H. Toguchi, Preparation of three-month depot injectable microspheres of leuprolin acetate using biodegradable polymers, Pharm. Res. 11 (1994) 1143-1147.
25. T. Niwa, H. Takeuchi, T. Hino, N. Kunou, Y Kawashima, In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method, J. Pharm. Sci. 83 (1994) 727-732.
26. H. Sah, R. Toddywala, Y.W. Chien, The influence of biodegradable microcapsule formulations on the controlled release of a protein, J. Control. Release 30 (1994) 201-211.
27. C. Yan, J.H. Resau, J. Hewtson, M. West, W.L. Rill, M. Kende, Characterization and morphological analysis of protein-loaded poly(lactide-co-glycolide) microparticles prepared by water-in-oil emulsion technique, J. Control. Release 32 (1994) 231-241.
28. R. Mehta, R. Jeyanthi, S. Calis, B.C. Thanoo, K.W Burton, P.P. DeLuca, Biodegradable microspheres as depot system for parenteral delivery of peptide drugs, J. Control. Release 29 (1994) 375-384.
29. W. Lu, T.G. Park, Protein release from poly(lactic-co-glycolic acid) microspheres: Protein stability problems, J. Pharm. Sci. Technol. 49 (1995) 13-19.
30. W. Lambert, K.D. Peck, Development of an in situ forming biodegradable poly-lactide-co-glycolide system for the controlled release of proteins, J. Control. Release 33 (1995) 189-195.
31. R. Nakaoka, Y Tabata, Y Ikada, Adjuvant effect of biodegradable poly(DL-lactic acid) granules capable of antigen release following intraperitoneal injection, Vaccine 14 (1996) 1671-1676.
32. T.G. Park, S. Cohen, R. Langer, Poly(L-lactic acid)/pluronic blends: Characterization of phase separation behavior, degradation, and morphology and use as protein-releasing matrices, Macromolecules 25 (1992) 116-122.
33. C.G. Pitt, Y. Cha, S.S. Shah, K.J. Zhu, Blend of PVA and PGLA: control of permeability and degradability of hydrogels by blending, J. Control. Release 19 (1992) 189-200.
34. S. Miyamoto, K. Takaoka, T. Okada, H. Yoshikawa, J. Hashimoto, S. Suzuki, K. Ono, Polylactic acid-polyethylene glycol block copolymer. A new biodegradable synthetic carrier for bone morphogenetic protein, Clin. Orthop. Relat. Res. 294 (1993) 333-343.
35. L. Yiuxin, C. Volland, T. Kissel, In vitro degradation and bovine serum albumin release of the ABA triblock co-polymer consisting of poly(L( + ) lactic acid), or poly(L( + ) lactic acid-co-glycolic acid) A-blocks attached to central polyoxyethylene B-blocks, J. Control. Release 32 (1994) 121-128.
36. J.C. Gautier, J.L. Grainger, A. Barbier, P. Dupont, D. Dussossoy, G. Pastor, P. Couvreur, Biodegradable nanoparticles for subcutaneous administration of growth hormone releasing factor (hGRF), J. Control. Release 20 (1992) 67-78.
37. C. Tasset, N. Barette, S. Thysman, J.M. Ketelslegers, D. Lemoine, V. Preat, Polyisobutylcyanoacrylate nanoparticles as sustained release system for calcitonin, J. Control. Release 33 (1995) 23-30.
38. E. Ron, T. Turek, E. Mathiowitz, M. Chasin, M. Hageman, R. Langer, Erosion kinetics of hydrolytically degradable polymer, Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 4176-4180.
39. Y. Tabata, S. Gutta, R. Langer, Controlled delivery systems for proteins using polyanhydride microspheres, Pharm. Res. 10 (1993) 487-496.
40. A. Göpferich, R. Gref, Y. Minamitake, L. Shieh, M.J. Alonso, Y. Tabata, R. Langer, Drug delivery from bioerodible polymers, in: J.L. Cleland, R. Langer (Eds.), Formulation and Delivery of Proteins and Peptides, ACS Symposium Series 567, Washington DC, 1994, pp. 242-277.
41. J. Heller, A.C. Cahng, G. Rodd, G.M. Grodsky, Release of insulin from a pH-sensitive poly(orthoester), Proc. Int. Symp. Control. Release Bioact. Mater. 15 (1989) 155-156.
42. J. Heller, K.V. Roskos, S.Y. Ng, P. Wuthrich, R. Duncan, L.W. Seymour, The use of poly(orthoester) in the treatment of cancer and in the pulsed release of proteins, Proc. Int. Symp. Control. Release Bioact. Mater. 19 (1992) 128-129.
43. A.K. Andrianov, L.G. Payne, Polyphosphazene hydrogel microspheres for protein delivery, in: S. Cohen, H. Bernstein (Eds.), Microparticulate systems for the delivery of proteins and vaccines. Drugs and the Pharmaceutical Sciences, Marcel Dekker, New York, (1996) pp. 127-148.
44. N.A. Peppas, J.E. Scott, Controlled release from poly(vinyl alcohol) gels prepared by freezing-thawing processes, J. Control. Release 18 (1992) 95-100.
45. J. Heller, R.F. Helwing, R.W. Baker, M.E. Tuttle, Controlled release of water-soluble macromolecules from bioerodible hydrogels, Biomaterials 4 (1983) 22-33.
46. N. Celebi, N. Erden, B. Gonul, M. Koz, Effects of epidermal growth factor dosage forms on dermal wound strength in mice, J. Pharm. Pharmacol. 46 (1994) 386-387.
47. J. Murray, L. Brwon, R. Langer, M. Klagsburn, A micro sustained release system for epidermal growth factor, In Vitro 19 (1993) 743-748.
48. E.B. Christine, W.M. Saltzman, Controlled growth factor delivery induces differential neurite outgrowth in three-dimensional cell cultures, J. Control. Release 24 (1993) 15-23.
49. S.L. Beck, L. Deguzman, W.P. Lee, Y. Xu, L.A. McFatridge, E.P. Amento, TGF-β1 accelerates wound healing: reversal of steroid-impaired healing ion tars and rabbits, Growth Factors 5 (1991) 295-304.
50. S.L. Beck, L. Deguzman, W.P. Lee, Y. Xu, L.A. McFatridge, N.A. Gillet, E.P. Amento, TGF-β1 induces bone closure in skull defect, J. Bone Miner. Res. 6 (1991) 1257-1265.
51. B. Matuszewska, M. Keogan, D.M. Fisher, K.A. Soper, C.A. Hoe, J.V. Bondi, Acidic fibroblast growth factor: Evaluation of topical formulations in a diabetic mouse wound healing model, Pharm. Res. 11 (1994) 65-71.
52. L. Illum, N.F. Farraj, A.N. Fisher, I. Gill, M. Miglietta, L.M. Bendetti, Hyaluronic acid microspheres as a nasal delivery system of insulin, J. Control. Release 29 (1994) 133-141.
53. E. Ghezzo, L.M. Bendetti, M. Rochira, F. Biviano, L. Callegaro, Hyaluronic acid derivative microspheres as NGF delivery devices: preparation methods and in vitro release characterization, Int. J. Pharm. 87 (1992) 21-29.
54. E.R. Edelman, E. Mathiowitz, R. Langer, M. Klagsburn, Controlled and modulated release of basic fibroblast growth factor, Biomaterials 12 (1991) 619-625.
55. E.C. Downs, N.E. Robertson, T.L. Riss, M.L. Plunkett, Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro, J. Cell Physiol. 152 (1992) 422-429.
56. D. Maysinger, I. Jalsenjak, A.C. Cuello, Microencapsulated nerve growth factor: effects on the forebrain neurons following devascularizing cortical lesions, Neurosci. Lett. 140 (1992) 71-74.
57. E.R. Edelman, M.A. Nugent, M.J. Karnovsky, Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition, Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 1513-1517.
58. R.J. Mumper, A.S. Hoffman, P.A. Puolakkainen, L.S. Bouchard, W.R. Gombota, Calcium-alginate beads for the oral delivery of transforming growth factor-β1 (TGF-β1): stabilization of TGF-β1 by the addition of polyacrylic acid within acid-treated beads, J. Control. Release 30 (1994) 241-245.
59. G.L. Brown, L.J. Curtsinger, M. White, R.O. Mitchell, J. Pietsch, R. Nordquist, A. vonFraunhofeer, G.S. Schultz, Acceleration of tensile strength incisions treated with EGF and TGF-β, Ann. Surg. 208 (1988) 788-794.
60. D.L. Gilbert, S.W. Kim, Macromolecular release from collagen monolithic device, J. Biomed. Mater. Res. 24 (1990) 1221-1239.
61. S. Yamamoto, T. Yoshimone, T. Fujita, R. Kuroda, T. Irie, K. Fujioka, T. Hatakeyama, Protective effect of NGF atelocollagen mini-pellet on the hippocampal delayed neuronal death in gerbils, Neurosci. Lett. 141 (1992) 161-165.
62. Y. Tabata, Y Ikada, Synthesis of gelatin microspheres containing Interferon, Pharm. Res. 6 (1989) 422-427.
63. B.G. Shinde, S. Erhan, Flexibilized gelatin film-based artificial skin model: II. Release kinetics of incorporated bioactive molecules, Bio-Med. Mater. Eng. 2 (1992) 127-131.
64. P.T. Goulmbek, R. Azhari, E.M. Jaffee, H.I. Levitsky, A. Lazenby, K. Leong, D. Paradoll, Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design, Cancer Res. 53 (1993) 5841-5844.
65. Y. Tabata, S. Hijikata, Y. Ikada, Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels, J. Control. Release 31 (1994) 189-199.
66. K. Yamada, Y. Tabata, K. Yamamoto, S. Miyamoto, I. Nagata, H. Kikuchi, Y Ikada, Potential efficacy of basic fibroblast growth factor in biodegradable hydrogels for skull bone regeneration, J. Neurosurg. 86 (1997) 871-875.
67. Y. Tabata, Y. Ikada, Potentiated in vivo biological activity of basic fibroblast growth factor by incorporation into polymer hydrogel microspheres. Proc. 4th Jpn. Int. SAMPE Symp. 4 (1995) 25-28.
68. P. Artursson, P. Edman, T. Laakso, I. Sjöholm, Characterization of polyacryl starch microparticles as carriers for protein drugs, J. Pharm. Sci. 73 (1984) 1507-1513.
69. L. Degling, P. Stjarnkvist, I. Sjöholm, Interferon-alpha in starch microparticles: Nitric oxide-generating activity in vitro and antileishmanial effect in mice, Pharm. Res. 6 (1993) 783-790.
70. P. Edman, B. Ekman, I. Sjoholm, Immobilization of proteins in microspheres of biodegradable polyacryldextran, J. Pharm. Sci. 69 (1980) 838-842.
71. H.-S. Ho, C.-C. Hsiao, T.D. Sokoloski, C.-Y. Chen, M.-T. Sheu, Fibrin-based drug delivery system. III: The evaluation of the release of macromolecules from microbeads, J. Control. Release 34 (1995) 65-70.
72. K. Park, W.S. Shalaby, H. Park, Biodegradable Hydrogels for Drug Delivery, Technomic Publishing, Lancaster, 1993.
73. M. Hara, Polyelectrolytes, Marcel Dekker, New York, 1993.
74. P. Dubin, J. Beck, R.M. Davies, D.H. Schulz, C. Thies, Macromolecular Complexes in Chemistry and Biology, Springer-Verlag, Berlin, 1994.
75. A.V. Kabanov, V.A. Kabanov, DNA complexes with polycations for the delivery of genetic material into cells, Bioconj. Chem. 6 (1995) 7-20.
76. F.D. Ledley, Nonviral gene therapy: The promise of genes as pharmaceutical products, Hum. Gene Ther. 6 (1995) 1129-1144.
77. E. Tomlinson, A.P. Rolland, Controllable gene therapy. Pharmaceutics of non-viral gene delivery systems, J. Control. Release 39 (1996) 357-372.
78. W.E. Long, H. Iwato, T. Lindheimer, and E.P. Goldberg, Preparation and drug release properties of albumin-polyasparatic acid-adriamycin microspheres. Polym. Prep. 24 (1983) 56-59.
79. Y Kawashima, T. Handa, A. Kasai, H. Takenaka, S.Y. Lin, Y Ando, Novel method for the preparation of controlled-release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphate-chitosan, J. Pharm. Sci. 74 (1985) 264-268.
80. A. Sawaya, J.P. Benoit, S. Benita, Binding mechanism of doxorubicin in ion-exchange albumin microcapsules, J. Pharm. Sci. 76 (1987) 475-480.
81. H.F.M. Cremers, J. Feijen, G. Kwon, Y.H. Bae, S.W. Kim, H.P.J.M. Noteborn, J.G. McVie, Albumin-heparin microspheres as carriers for cytostatic agents, J. Control. Release 11 (1990) 167-179.
82. A. Veis, The Macromolecular Chemistry of Gelatin, Academic Press, New York, 1964.
83. G.S. Kwon, Y.H. Bae, H. Cremers, J. Feijen, S.W. Kim, Release of proteins via ion exchange from albumin-heparin microspheres, J. Control. Release 22 (1992) 83-94.
84. K. Nakamae, T. Nizuka, T. Miyata, M. Furukawa, T. Nishino, Kato, T. Inoue, A.S. Hoffman, Y. Kanzaki, Lysozyme loading and release from hydrogels carrying pendant phosphate groups, J. Biomater. Sci., Polym. Ed. (1997), in press.
85. T. Fujiwara, K. Sakagami, J. Matsuoka, S. Shiozaki, K. Fujioka, Y. Takada, S. Uchida, T. Onoda, K. Otira, Augmentation of antitumor effect on syngeneic murine solid tumors by IL-2 mini-pellet, Biotherapy 3 (1991) 203-209.
86. K. Fujioka, Y. Takada, S. Sato, T. Miyata, Long-acting delivery system of Interferon: IFN minipellet, J. Control. Release 33 (1995) 317-323.
87. M. Munirzzaman, Y. Tabata, Y. Ikada, Complexation of basic fibroblast growth factor with gelatin for tissue engineering, J. Biomater. Sci., Polym. Ed. (1997) in press.
88. K. Burczak, T. Fujisato, M. Hatada, Y Ikada, Protein permeation through polymer membranes for hybrid-type artificial pancreas, Y Proc. Jpn. Acad. 67 (1991) 83-88.
89. M. Klagbrun, A. Baird, A dual receptor system is required for basic fibroblast growth factor, Cell 67 (1991) 229-231.
90. N. Gospodarowizc, L. Ferrara, L. Schweigerer, G. Neufeld, Structural characterization and biological functions of fibroblast growth factor, Endocr. Rev. 8 (1987) 95-114.
91. D.B. Rifkin, D. Moscatelli, Recent development in the cell biology of basic fibroblast growth factor, J. Cell Biol. 109 (1989) 1-6.
92. Y. Tabata, A. Yagano, Y Ikada, Biodegradation of hydrogel carrier incorporating fibroblast growth factor, Tissue Engineering, in press.
93. S. Hijikata, Y. Tabata, Y. Ikada, Distribution of basic fibroblast growth factor throughout ionic hydrogels, Polym. Preprint Jpn. 43 (1995) 34-35.
94. N. Gospodarowizc, Biological activities of fibroblast growth factor, Ann. NY Acad. Sci. 638 (1991) 1-8.
95. P. Buntrock, K.D. Jentzsch, G. Mender, Stimulation of wound healing, using brain extract with fibroblast growth factor (FGF) activity. II. Histological and morphometric examination of cells and capillaries, Exp. Pathol. 21 (1982) 62-67.
96. G.S. McGee, J.M. Cavidson, A. Buckley, A. Sommer, S.C. Woodward, A.M. Aquino, R. Barbour, A.A. Demetrious, Recombinant basic fibroblast growth factor accelerates wound healing, J. Surg. Res. 45 (1988) 145-153.
97. S.B. Rodan, G. Wesolowski, K.A. Thomas, K. Yoon, G.A. Rodan, Effects of acidic and basic fibroblast growth factors on osteoblastic cells, Connect. Tissue Res. 20 (1989) 283-288.
98. H. Kawaguchi, T. Kurokawa, K. Hanada, Y. Hiyama, M. Tamura, E. Ogata, T. Matsumoto, Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats, Endocrinology 135 (1994) 774-781.
99. T. Nakamura, K. Hanada, M. Tamura, T. Shibanushi, H. Nigi, M. Tagawa, S. Fukumoto, T. Matsumoto, Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats, Endocrinology 136 (1995) 1276-1284.
100. P. Cuevas, J. Burgos, A. Baird, Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo, Biochem. Biophys. Res. Commun. 156 (1988) 611-618.
101. S.B. Trippel, Growth factor actions on articular cartilage, J. Rheumatol. 22 (1995) 129-132.
102. P. Aebischer, A.N. Salessiotis, S.R. Winn, Basic fibroblast growth factor released from synthetic guidance channels facilitates peripheral nerve regeneration across long nerve gaps, J. Neurosci. Res. 23 (1989) 282-289.
103. A. Laquerriere, P. Peulve, O. Jin, J. Tiollier, M. Tardy, H. Vaudry, J. Hemet, M. Trdie, Effect of basic fibroblast growth factor and α-melanocytic stimulating hormone on nerve regeneration through a collagen channel, Microsurgery 15 (1994) 203-210.
104. J. Taipale, J. Keski-Oja, Growth factors in the extracellular matrix, FASEB J. 11 (1997) 51-59.
105. H.-W. Kang, Y. Tabata, Y. Ikada, Preparation of injectable gelatin hydrogels for tissue engineering, Proc. 3rd Far-Eastern Symp. Biomed. Mater. (1997) 6-7.